-
Carvacrol in ROS-Sensitive TRP Assays
2026-10-01
Carvacrol, also known as 5-isopropyl-2-methylphenol, offers a useful way to separate oxidative modification of TRPA1 from loss of receptor function. This article translates recent redox-channel findings into practical assay design for cell cycle, apoptosis, and ion-channel research.
-
Pam3CSK4 TFA: TLR1/2 Assay Workflows
2026-09-30
Pam3CSK4 TFA enables controlled TLR1/2 stimulation for cytokine profiling, pathway-competence testing, and translational innate-immunity studies. Its defined receptor activity is especially useful when ex vivo stimulation must be interpreted alongside biomarkers such as IL-17A rather than confused with evidence of active infection.
-
Azithromycin Workflows for Infection Research
2026-09-30
Azithromycin supports mechanism-guided bacterial infection research, resistance profiling, and carefully controlled exploratory animal studies. This workflow connects susceptibility testing with compound stability checks and microbiome-aware endpoints so apparent treatment failure is easier to interpret.
-
CP-673451: Selective PDGFRα/β Inhibitor Workflow
2026-09-29
CP-673451 provides a nanomolar tool for separating PDGFRα/β signaling from activity at several other receptor tyrosine kinases. This practical guide connects phosphorylation assays, angiogenesis inhibition assays, ATRX-stratified glioma experiments, and xenograft interpretation with formulation and troubleshooting guidance.
-
Ko 143: Reliable BCRP Inhibition in Cell Assays
2026-09-29
This scenario-driven guide shows how Ko 143 (SKU A3533) can improve interpretation of viability, cytotoxicity, and transporter assays by separating BCRP-mediated efflux from solvent effects and nonspecific toxicity. It integrates product performance data with practical controls, protocol parameters, and limitations when translating cell findings to in vivo exposure.
-
Sensitive Methods for Detecting SARS-CoV-2 RNA
2026-09-28
The chapter frames sensitive nucleic acid testing as a central way to reduce false-negative SARS-CoV-2 results, and explains why RT-PCR became a key diagnostic approach. Its practical contribution is a clear comparison of diagnostic categories and the steps linking viral RNA to an amplified, detectable signal, while highlighting that assay sensitivity depends on the full workflow.
-
HMGCS2, Lyso-PC, and Pulmonary Fibrosis
2026-09-27
Yang et al. identify injured type II alveolar epithelial cells as a source of accumulated lysophosphatidylcholines in experimental pulmonary fibrosis, linking reduced HMGCS2 to fibroblast activation. Their experiments suggest that restoring epithelial HMGCS2 can improve lipid handling through a PPARα–CPT1A/CPT2 pathway, while leaving the contributions of individual Lyso-PC species to be resolved.
-
EPI-001: Interpreting AR-Driven Cancer Biology
2026-09-26
EPI-001 is an androgen receptor N-terminal domain inhibitor that enables research beyond ligand-binding blockade. This article examines how to interpret AR and ARv7 findings across prostate and triple-negative breast cancer models, and how to design assays that distinguish pathway modulation from broader effects on cell behavior.
-
LAG-3–TCR Proximity Suppresses T Cells and Autoimmunity
2026-09-26
Du et al. show that LAG-3 suppression depends not simply on MHC class II binding, but on LAG-3 being positioned near the T cell receptor, where it can disrupt CD3ε–Lck association. An Fc-attenuated LAG-3/TCR bispecific antibody used this proximity principle to suppress CD4+ and CD8+ T cells and alleviate disease in mouse autoimmune models.
-
From mRNA Design to Translational Proof
2026-09-25
A translational framework for using modified mRNA reporters to separate delivery, expression, and biological function—while interpreting each result within its limits.
-
CBD Reduces Orofacial Pain and Affective Deficits
2026-09-25
In mouse models, cannabidiol reduced acute orofacial inflammatory pain and, in a chronic pain model, improved pain-related affective and cognitive behaviors. The study connects peripheral CB2-associated anti-inflammatory effects with central endocannabinoid changes and normalized serotonin activity, while leaving important questions about dosing, mechanism, and translation to humans.
-
IPA-3: Practical Workflows for Pak1 Research
2026-09-24
IPA-3 provides a way to probe group I Pak regulation without competing at the ATP-binding site, supporting kinase assays and cell-based studies of signaling, motility, and inflammation. This guide pairs practical starting conditions with controls and clear limits on what cross-domain evidence can—and cannot—show.
-
Tacalcitol Monohydrate: Pathway-Specific Assay Design
2026-09-24
Tacalcitol monohydrate is a synthetic analog of vitamin D3 whose effects depend on VDR-linked transcription, cell type, and experimental context. This article connects practical assay design with a distinct vitamin K thrombosis study to clarify what pathway-focused evidence can—and cannot—tell researchers.
-
Tolazoline Workflows for Receptor and Islet Assays
2026-09-23
Tolazoline provides a concentration-aware tool for separating α2-adrenergic receptor effects from ATP-sensitive potassium channel and secretory responses. This guide connects airway smooth muscle and islet workflows with practical dosing, controls, troubleshooting, and a cautious translation of insulin-signaling insights from Alzheimer’s disease research.
-
2',7'-Dichlorofluorescein Diacetate ROS Workflow
2026-09-23
Build a practical intracellular ROS measurement workflow with 2',7'-Dichlorofluorescein diacetate for microscopy, flow cytometry, and plate-based assays. Learn how to apply the probe to redox-responsive pancreatic cancer nanocarriers while avoiding the common mistake of treating a broad oxidative-stress signal as a species-specific measurement.